Clinical significance of regulatory B cells in the peripheral blood of patients with oesophageal cancer
B cell subsets have been found to exhibit a negative regulatory function, like Tregs. The present study investigates the effects of CD5+CD19+ interleukin (IL)-10 (B10) on the occurrence and development of oesophageal carcinoma by analysing B10 levels in the peripheral blood of patients with oesophag...
Gespeichert in:
| Veröffentlicht in: | Central-European journal of immunology 2015-01, Vol.40 (2), p.263-265 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 265 |
|---|---|
| container_issue | 2 |
| container_start_page | 263 |
| container_title | Central-European journal of immunology |
| container_volume | 40 |
| creator | Qian, Li Bian, Guang-Rong Zhou, Yan Wang, Yan Hu, Juan Liu, Xia Xu, Yan |
| description | B cell subsets have been found to exhibit a negative regulatory function, like Tregs. The present study investigates the effects of CD5+CD19+ interleukin (IL)-10 (B10) on the occurrence and development of oesophageal carcinoma by analysing B10 levels in the peripheral blood of patients with oesophageal carcinoma. Peripheral blood of 120 oesophageal cancer patients and 120 healthy controls were collected, and regulatory B cell counts were determined by flow cytometry. The level of B10 cells in the peripheral blood of patients with oesophageal carcinoma was significantly higher than that in healthy controls (p < 0.05). In addition, B10 levels in stage III-IV patients (3.5 ±0.7%) were higher than those in stage I-II patients (2.5 ±0.6%), which were in turn higher than those in the healthy controls (1.3 ±0.3%). The level of B10 increased with clinical progression of oesophageal cancer, suggesting that B10 cells may influence the development or progression of oesophageal cancer. |
| doi_str_mv | 10.5114/ceji.2015.52840 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4637401</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3775983611</sourcerecordid><originalsourceid>FETCH-LOGICAL-p294t-a69b58705ffd56ae836b61d9cb720c36ca6c0a7d9e3e23a31c57cc1a1d2184b03</originalsourceid><addsrcrecordid>eNpdkUtLxDAUhYMojq-1Owm4cdMx77YbQQdfILjRdUnT2zZDp6lJq8y_N-oo6uoeuN89nMNF6JiSuaRUnBtY2jkjVM4lywTZQntUCZEIysR21IKphOeUzdB-CEtCVE6zfBfNmJIyJYLtoWbR2d4a3eFgm97WUfYGsKuxh2bq9Oj8Gl9hA10XsO3x2AIewNuhBR-Pys656oMe9GihHwN-s2OLHQQ3tLqBiHwa-kO0U-suwNFmHqDnm-unxV3y8Hh7v7h8SAaWizHRKi9llhJZ15VUGjKuSkWr3JQpI4Yro5UhOq1y4MC45tTI1BiqacVoJkrCD9DFl-8wlSuoTMwUcxaDtyvt14XTtvi76W1bNO61EIqngtBocLYx8O5lgjAWKxs-6use3BQKmnIm81QpFdHTf-jSTb6P9SJFuJRESBmpk9-JfqJ8_4C_A0ZLixA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1703550455</pqid></control><display><type>article</type><title>Clinical significance of regulatory B cells in the peripheral blood of patients with oesophageal cancer</title><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Qian, Li ; Bian, Guang-Rong ; Zhou, Yan ; Wang, Yan ; Hu, Juan ; Liu, Xia ; Xu, Yan</creator><creatorcontrib>Qian, Li ; Bian, Guang-Rong ; Zhou, Yan ; Wang, Yan ; Hu, Juan ; Liu, Xia ; Xu, Yan</creatorcontrib><description>B cell subsets have been found to exhibit a negative regulatory function, like Tregs. The present study investigates the effects of CD5+CD19+ interleukin (IL)-10 (B10) on the occurrence and development of oesophageal carcinoma by analysing B10 levels in the peripheral blood of patients with oesophageal carcinoma. Peripheral blood of 120 oesophageal cancer patients and 120 healthy controls were collected, and regulatory B cell counts were determined by flow cytometry. The level of B10 cells in the peripheral blood of patients with oesophageal carcinoma was significantly higher than that in healthy controls (p < 0.05). In addition, B10 levels in stage III-IV patients (3.5 ±0.7%) were higher than those in stage I-II patients (2.5 ±0.6%), which were in turn higher than those in the healthy controls (1.3 ±0.3%). The level of B10 increased with clinical progression of oesophageal cancer, suggesting that B10 cells may influence the development or progression of oesophageal cancer.</description><identifier>ISSN: 1426-3912</identifier><identifier>EISSN: 1644-4124</identifier><identifier>DOI: 10.5114/ceji.2015.52840</identifier><identifier>PMID: 26557042</identifier><language>eng</language><publisher>Poland: Termedia Publishing House</publisher><subject>Short Communication</subject><ispartof>Central-European journal of immunology, 2015-01, Vol.40 (2), p.263-265</ispartof><rights>Copyright Termedia Publishing House 2015</rights><rights>Copyright © Central European Journal of Immunology 2015 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637401/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637401/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26557042$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Qian, Li</creatorcontrib><creatorcontrib>Bian, Guang-Rong</creatorcontrib><creatorcontrib>Zhou, Yan</creatorcontrib><creatorcontrib>Wang, Yan</creatorcontrib><creatorcontrib>Hu, Juan</creatorcontrib><creatorcontrib>Liu, Xia</creatorcontrib><creatorcontrib>Xu, Yan</creatorcontrib><title>Clinical significance of regulatory B cells in the peripheral blood of patients with oesophageal cancer</title><title>Central-European journal of immunology</title><addtitle>Cent Eur J Immunol</addtitle><description>B cell subsets have been found to exhibit a negative regulatory function, like Tregs. The present study investigates the effects of CD5+CD19+ interleukin (IL)-10 (B10) on the occurrence and development of oesophageal carcinoma by analysing B10 levels in the peripheral blood of patients with oesophageal carcinoma. Peripheral blood of 120 oesophageal cancer patients and 120 healthy controls were collected, and regulatory B cell counts were determined by flow cytometry. The level of B10 cells in the peripheral blood of patients with oesophageal carcinoma was significantly higher than that in healthy controls (p < 0.05). In addition, B10 levels in stage III-IV patients (3.5 ±0.7%) were higher than those in stage I-II patients (2.5 ±0.6%), which were in turn higher than those in the healthy controls (1.3 ±0.3%). The level of B10 increased with clinical progression of oesophageal cancer, suggesting that B10 cells may influence the development or progression of oesophageal cancer.</description><subject>Short Communication</subject><issn>1426-3912</issn><issn>1644-4124</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNpdkUtLxDAUhYMojq-1Owm4cdMx77YbQQdfILjRdUnT2zZDp6lJq8y_N-oo6uoeuN89nMNF6JiSuaRUnBtY2jkjVM4lywTZQntUCZEIysR21IKphOeUzdB-CEtCVE6zfBfNmJIyJYLtoWbR2d4a3eFgm97WUfYGsKuxh2bq9Oj8Gl9hA10XsO3x2AIewNuhBR-Pys656oMe9GihHwN-s2OLHQQ3tLqBiHwa-kO0U-suwNFmHqDnm-unxV3y8Hh7v7h8SAaWizHRKi9llhJZ15VUGjKuSkWr3JQpI4Yro5UhOq1y4MC45tTI1BiqacVoJkrCD9DFl-8wlSuoTMwUcxaDtyvt14XTtvi76W1bNO61EIqngtBocLYx8O5lgjAWKxs-6use3BQKmnIm81QpFdHTf-jSTb6P9SJFuJRESBmpk9-JfqJ8_4C_A0ZLixA</recordid><startdate>20150101</startdate><enddate>20150101</enddate><creator>Qian, Li</creator><creator>Bian, Guang-Rong</creator><creator>Zhou, Yan</creator><creator>Wang, Yan</creator><creator>Hu, Juan</creator><creator>Liu, Xia</creator><creator>Xu, Yan</creator><general>Termedia Publishing House</general><general>Polish Society of Experimental and Clinical Immunology</general><scope>NPM</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150101</creationdate><title>Clinical significance of regulatory B cells in the peripheral blood of patients with oesophageal cancer</title><author>Qian, Li ; Bian, Guang-Rong ; Zhou, Yan ; Wang, Yan ; Hu, Juan ; Liu, Xia ; Xu, Yan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p294t-a69b58705ffd56ae836b61d9cb720c36ca6c0a7d9e3e23a31c57cc1a1d2184b03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Short Communication</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Qian, Li</creatorcontrib><creatorcontrib>Bian, Guang-Rong</creatorcontrib><creatorcontrib>Zhou, Yan</creatorcontrib><creatorcontrib>Wang, Yan</creatorcontrib><creatorcontrib>Hu, Juan</creatorcontrib><creatorcontrib>Liu, Xia</creatorcontrib><creatorcontrib>Xu, Yan</creatorcontrib><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Central-European journal of immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Qian, Li</au><au>Bian, Guang-Rong</au><au>Zhou, Yan</au><au>Wang, Yan</au><au>Hu, Juan</au><au>Liu, Xia</au><au>Xu, Yan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical significance of regulatory B cells in the peripheral blood of patients with oesophageal cancer</atitle><jtitle>Central-European journal of immunology</jtitle><addtitle>Cent Eur J Immunol</addtitle><date>2015-01-01</date><risdate>2015</risdate><volume>40</volume><issue>2</issue><spage>263</spage><epage>265</epage><pages>263-265</pages><issn>1426-3912</issn><eissn>1644-4124</eissn><abstract>B cell subsets have been found to exhibit a negative regulatory function, like Tregs. The present study investigates the effects of CD5+CD19+ interleukin (IL)-10 (B10) on the occurrence and development of oesophageal carcinoma by analysing B10 levels in the peripheral blood of patients with oesophageal carcinoma. Peripheral blood of 120 oesophageal cancer patients and 120 healthy controls were collected, and regulatory B cell counts were determined by flow cytometry. The level of B10 cells in the peripheral blood of patients with oesophageal carcinoma was significantly higher than that in healthy controls (p < 0.05). In addition, B10 levels in stage III-IV patients (3.5 ±0.7%) were higher than those in stage I-II patients (2.5 ±0.6%), which were in turn higher than those in the healthy controls (1.3 ±0.3%). The level of B10 increased with clinical progression of oesophageal cancer, suggesting that B10 cells may influence the development or progression of oesophageal cancer.</abstract><cop>Poland</cop><pub>Termedia Publishing House</pub><pmid>26557042</pmid><doi>10.5114/ceji.2015.52840</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1426-3912 |
| ispartof | Central-European journal of immunology, 2015-01, Vol.40 (2), p.263-265 |
| issn | 1426-3912 1644-4124 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4637401 |
| source | DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; PubMed Central Open Access |
| subjects | Short Communication |
| title | Clinical significance of regulatory B cells in the peripheral blood of patients with oesophageal cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T03%3A41%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20significance%20of%20regulatory%20B%20cells%20in%20the%20peripheral%20blood%20of%20patients%20with%20oesophageal%20cancer&rft.jtitle=Central-European%20journal%20of%20immunology&rft.au=Qian,%20Li&rft.date=2015-01-01&rft.volume=40&rft.issue=2&rft.spage=263&rft.epage=265&rft.pages=263-265&rft.issn=1426-3912&rft.eissn=1644-4124&rft_id=info:doi/10.5114/ceji.2015.52840&rft_dat=%3Cproquest_pubme%3E3775983611%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1703550455&rft_id=info:pmid/26557042&rfr_iscdi=true |